Get started
Author

M. Galassi

Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012 · E. Terzi, R. Golfieri, et al. · Journal of Hepatology · 154
Impact of gadoxetic acid (Gd‐ EOB ‐ DTPA )‐enhanced magnetic resonance on the non‐invasive diagnosis of small hepatocellular carcinoma: a prospective study
2012 · A. Granito, M. Galassi, et al. · Alimentary Pharmacology & Therapeutics · 118
Characterization of Primary and Recurrent Nodules in Liver Cirrhosis Using Contrast-Enhanced Ultrasound: Which Vascular Criteria Should Be Adopted?
2013 · S. Leoni, F. Piscaglia, et al. · Ultraschall in der Medizin - European Journal of Ultrasound · 72
968 Impact of Gadoxetic Acid (gd-eob-dtpa)-enhanced Magnetic Resonance on the Non-invasive Diagnosis of Small Hepatocellular Carcinoma
2011 · A. Granito, M. Galassi, et al. · Journal of Hepatology · 2
PDF
A case of inflammatory ascites
2014 · E. Guidetti, M. Galassi, et al. · Acta Clinica Belgica · 1
Natural history of hypovascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced mr imaging in cirrhotic patients during surveillance program
2017 · Luca Ielasi, Alessandro Granito, et al.
Appearance of combined hepatocellular cholangiocarcinoma in cirrhosis at contrast enhanced imaging techniques
2014 · E. Sagrini, M. Iavarone, et al. · Digestive and Liver Disease
1043 IN HEPATOCELLULAR CARCINOMA miR-494 IS REGULATED BY EPIGENETIC MECHANISMS AND TARGETS p27, PTEN AND PUMA
2013 · F. Fornari, M. Milazzo, et al. · Journal of Hepatology
F-53 In hepatocellular carcinoma miR-494 is regulated by epigenetic mechanisms and targets p27, PTEN and PUMA
2013 · F. Fornari, M. Milazzo, et al. · Digestive and Liver Disease
292 in Hepatocellular Carcinoma Mir-519d Is Upregulated by P53 and Dna Hypomethylation
2012 · M. Milazzo, F. Fornari, et al. · Journal of Hepatology
271 Mir-221/mdm2/p53 Control Loop Sensitizes Hepatocellular Carcinoma Cells to Anti-cancer Treatments
2012 · F. Fornari, M. Milazzo, et al. · Journal of Hepatology
T-50 In hepatocellular carcinoma miR-519d is upregulated by p53 and DNA hypomethylation
2012 · M. Milazzo, F. Fornari, et al. · Digestive and Liver Disease
T-10 MiR-221/Mdm2/p53 control loop sensitizes hepatocellular carcinoma cells to anti-cancer treatments
2012 · F. Fornari, M. Milazzo, et al. · Digestive and Liver Disease
272 Mir-338-3p Is Down-regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting Cyclind1 Mainly at 2397-2403nt of Cyclind1 3 Utr
2012 · Francesca Fornari, Maddalena Milazzo, et al.
1015 the Challenge of Treating Hcc in Child-pugh B: Need for Subclassification
2011 · F. Piscaglia, E. Terzi, et al. · Journal of Hepatology
1001 Rapid, Marked Wash Out at Contrast Enhanced Ultrasound in Nodules in Cirrhosis Should Raise the Suspicion of Cholangiocarcinoma
2011 · M. Galassi, F. Piscaglia, et al. · Journal of Hepatology
T-17 Impact of Gadoxetic acid (Gd-EOB-DTPA)-enhanced MR on the non-invasive diagnosis of small hepatocellular carcinoma
2011 · M. Galassi, A. Granito, et al. · Digestive and Liver Disease
MiR-221 regulates p27/kip1 in hepatocellular carcinoma
2008 · F. Fornari, L. Gramantieri, et al. · Digestive and Liver Disease
327 Micro-rna-221 Regulates P27/kip1 in Hepatocellular Carcinoma
2008 · F. Fornari, L. Gramantieri, et al. · Journal of Hepatology
PDF
Safety and activity of sorafenib in advanced renal cell cancer: A single institution experience
2007 · E. Bajetta, G. Procopio, et al. · Journal of Clinical Oncology
Works count: 21
Citation count: 347
H-index: 3
I10-index: 3
Year
Topic
Type